In ovarian cancer, high expression of TLR4 could activate NF-κB signaling pathway, thus up-regulated ALKBH5 to influence the m6A methylation of NANOG, which further promoted carcinogenesis in ovarian cancer [29]. Here, NANOG is linked to ovarian carcinoma.